ImClone Systems wants to create identically successful cancer drug candidates. The company, a subsidiary of Eli Lilly, is focused on the development of oncology-related antibody therapies. The biotech research firm's only commercial product, Erbitux, is approved for treatment of colorectal cancer, as well as head and neck cancers. ImClone Systems co-promotes the drug with Bristol-Myers Squibb (BMS) in North America and with Merck KGaA elsewhere. The company is continuing to develop Erbitux as a possible treatment for other kinds of cancer, including lung cancer. It also...
This is the employer's chance to tell you why you should work for them. The information provided is from their perspective.
Employees say it's “OK” 26 ratings
100% of the CEO 2 ratings
Managing Director and President
Former Senior Research Associate in New York, NY (US)
Pros: Great new facility. Lots of amenities in the NYC campus building. Research Associates for the most part are a great group of people to work with. Benefits are okay. Once ImClone was fully integrated into Lilly, PPOs were no longer an option for… – Full Review
Accepted Offer – Interviewed in Branchburg, NJ (US) Apr 2009 – Reviewed Jan 30, 2013
Interview Details Phone interview initially then I interviewed with 6 different supervisors in the group from different functions, got a tour of the labs, asked which area I'd prefer to work in, spoke with an HR representative. I was called back and asked to start right away, but was able to push it off until after… – Full Interview
Which area I'd want to work in of the different vacancies, which was difficult because I didn't know much about them at the time, specific questions about my internships, biggest weakness – Answer Question
Let us know if we're missing any workplace or industry recognition –